An update on contraindications for lung function testing

Republished review: An update on contraindications for lung function testing.

Guidelines on contraindications for lung function tests have been based on expert opinion from >30 years ago. High-risk contraindications to lung function testing are associated with cardiovascular complications such as myocardial infarct, pulmonary embolism or ascending aortic aneurysm. Slightly less risky but still serious contraindications are predominantly centred on recovery from ma...

An update on contraindications for lung function testing

Guidelines on contraindications for lung function tests have been based on expert opinion from >30 years ago. High-risk contraindications to lung function testing are associated with cardiovascular complications such as myocardial infarct, pulmonary embolism or ascending aortic aneurysm. Slightly less risky but still serious contraindications are predominantly centred on recovery from major tho...

European standards for lung function testing: 1993 update.

Update on endoscopic pancreatic function testing.

Hormone-stimulated pancreatic function tests (PFTs) are considered the gold standard for measuring pancreatic exocrine function. PFTs involve the administration of intravenous secretin or cholecystokinin, followed by collection and analysis of pancreatic secretions. Because exocrine function may decline in the earliest phase of pancreatic fibrosis, PFTs are considered accurate for diagnosing ch...

Standardised lung function testing.

In 1983 a supplement entitled "Standardised Lung Function Testing" was published by one of our parent journals, the Bulletin Europeen de Physiopathologie Respiratoire [1]. This seminal and widely quoted work reported the recommendations of a Working Party established originally under the auspices of the European Community for Coal and Steel and reflecting the long-standing interest of that body...